- Home
- MRNS vs FAM Comparison
MRNS vs FAM Comparison
Compare MRNS & FAM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MRNS
- FAM
- Stock Information
- Founded
- MRNS 2003
- FAM 2004
- Country
- MRNS United States
- FAM United States
- Employees
- MRNS N/A
- FAM N/A
- Industry
- MRNS Biotechnology: Pharmaceutical Preparations
- FAM Finance/Investors Services
- Sector
- MRNS Health Care
- FAM Finance
- Exchange
- MRNS Nasdaq
- FAM Nasdaq
- Market Cap
- MRNS 76.0M
- FAM 64.4M
- IPO Year
- MRNS 2014
- FAM N/A
- Fundamental
- Price
- MRNS $1.50
- FAM $6.49
- Analyst Decision
- MRNS Buy
- FAM
- Analyst Count
- MRNS 7
- FAM 0
- Target Price
- MRNS $8.00
- FAM N/A
- AVG Volume (30 Days)
- MRNS 390.0K
- FAM 33.5K
- Earning Date
- MRNS 11-05-2024
- FAM 01-01-0001
- Dividend Yield
- MRNS N/A
- FAM 10.90%
- EPS Growth
- MRNS N/A
- FAM N/A
- EPS
- MRNS N/A
- FAM N/A
- Revenue
- MRNS $30,263,000.00
- FAM N/A
- Revenue This Year
- MRNS $20.42
- FAM N/A
- Revenue Next Year
- MRNS $57.03
- FAM N/A
- P/E Ratio
- MRNS N/A
- FAM N/A
- Revenue Growth
- MRNS 16.56
- FAM N/A
- 52 Week Low
- MRNS $1.05
- FAM $5.38
- 52 Week High
- MRNS $11.26
- FAM $6.67
- Technical
- Relative Strength Index (RSI)
- MRNS 55.91
- FAM 53.24
- Support Level
- MRNS $1.38
- FAM $6.38
- Resistance Level
- MRNS $1.43
- FAM $6.47
- Average True Range (ATR)
- MRNS 0.07
- FAM 0.05
- MACD
- MRNS 0.00
- FAM -0.01
- Stochastic Oscillator
- MRNS 47.62
- FAM 45.00
About MRNS Marinus Pharmaceuticals Inc.
Marinus Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is focused on developing and commercializing innovative therapeutics to treat epilepsy and neuropsychiatric disorders. Marinus manages the business in one segment, which is the identification and development of neuropsychiatric therapeutics. The Company is developing ganaxolone for multiple epilepsy and other neuropsychiatric indications, including adjunctive, or add-on, therapy for the treatment of drug-resistant focal onset seizures; status epilepticus; Fragile X Syndrome, and PCDH19-RE.
About FAM First Trust/abrdn Global Opportunity Income Fund of Beneficial Interest
First Trust/aberdeen Global Oppo Income is a United States-based diversified, closed-end management investment company. The fund's primary investment objective is to seek a high level of current income while its secondary objective is to seek capital appreciation. The fund seeks to achieve these objectives by investing its managed assets in the world bond markets through a diversified portfolio of investment-grade and below-investment-grade government and corporate debt securities.